BioSpace News Archive

Motus GI Holdings, Inc. today provided an update on the development of its Pure-Vu® EVS system compatible with gastroscopes used during upper gastrointestinal (GI) endoscopy procedures to remove blood, blood clots and debris in order to provide a clear field-of-view for the endoscopist.

BioNTech SE (Nasdaq: BNTX, “BioNTech”) reached the next milestone in the establishment of scalable mRNA vaccine production in Africa.

Gravity Diagnostics, a CAP-accredited, CLIA-certified laboratory licensed in all 50 states, has officially welcomed Erica Adams as their Director of Compliance.

Nuevocor, a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place in San Francisco, CA, USA from January 9 to 11, 2023.

Abbott (NYSE: ABT) today announced that its FreeStyle Libre® 3 sensor is now compatible with the mylife™ Loop solution from partners, Ypsomed and CamDiab, creating a smart, automated process to deliver insulin based on real-time glucose data.

Anocca, a fully integrated cell therapy biotechnology company, today announced that it has secured EUR 25 million Venture Debt financing from the European Investment Bank (EIB).

Paige today announced it has published the results of a pivotal study demonstrating accuracy gains in pathologists’ diagnosis of prostate cancer when using Paige Prostate Detect, an FDA-authorized AI software that assists pathologists in the detection of foci that are suspicious for cancer during the review of scanned whole slide images (WSI) from prostate needle biopsies.

The global life science analytics market size was exhibited at USD 9.34 billion in 2022 and it is expected to hold around USD 18.12 billion by 2030, growing at a CAGR of 8.68% from 2022 to 2030.

Intelivation Technologies, a medical device company with a cutting-edge orthopedic portfolio, announced today several case highlights with the TruTrack™ Memory Staple System.

Bluestar Genomics today announced the company’s U.S. and international commercialization of its first test for early detection of pancreatic cancer in high-risk patients, and unveiled a new name, ClearNote Health™.